HIRA to designate hospitals for Soliris
Published: 2012-06-04 06:57:00
Updated: 2012-06-04 06:57:00
From August 1, the national health insurance will cover Soliris (eculizumab) as a treatment for patients in Korea with paroxysmal nocturnal hemoglobinuria (PNH), the Health Insurance Review and Assessment Service said Thursday.
PNH is an ultra-rare, debilitating and life-threatening blood diso...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
